Magnus Hook

Compositions and use of a fibrinogen binding motif present in EFB and COA for therapeutics and vaccines against

Crystal structure of clumping factor A in complex with fibrinogen derived peptide and uses thereof

Targeting of ligand binding sites in ClfA

Prokaryotic collagen therapeutics for postoperative adhesions

Designer collagens and use thereof

Compositions and the Use of Fibrinogen Binding Motif Presence in EFB and COA for Vaccine Against Staphylococcus Aureus and Drug Delivery

Crystal Structure of Staphylococcus Aureus Clumping Factor A in Complex with Fibrinogen Derived Peptide and Uses Thereof

CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A IN COMPLEX WITH FIBRINOGEN DERIVED PEPTIDE AND USES THEREOF

Designer collagens and use thereof

Specific binding sites in collagen for integrins and use thereof

CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A IN COMPLEX WITH FIBRINOGEN DERIVED PEPTIDE AND USES THEREOF

SPECIFIC BINDING SITES IN COLLAGEN FOR INTEGRINS AND USE THEREOF

Designer collagens and use thereof

Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains

Prokaryotic collage-like proteins and uses thereof

Monoclonal antibodies recognizing a coagulase-negative protein

Multicomponent vaccines

Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby

Multicomponent vaccines

Crystal structure of clumping factor A in complex with fibrinogen derived peptide and uses thereof

Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby

Prokaryotic collagen-like proteins and uses thereof

Specific binding sites in collagen for integrins and use thereof

Formation of superfibronectin by BBK32 and uses therefor

Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor

Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use

Prokaryotic collagen-like proteins and uses thereof

Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use

Treatment of infections utilizing antibodies that bind to fibronectin binding proteins

Specific binding sites in collagen for integrins and use thereof

Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus

Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation

Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from

Decorin proteoglycan inhibitor of fibrinogen blood clotting

Use of glycosoaminoglycans for the prevention and treatment of sepsis

Staphylococcal immunotherapeutics via donor selection and donor stimulation

Collagen-binding MSCRAMMs of Bacillus anthracis and uses therefor

Staphylococcal immunotherapeutics via donor selection and donor stimulation

Prokaryotic collagen-like proteins and uses thereof

Method of inhibiting Candida-related infections using donor selected or donor stimulated immunoglobulin compositions

Prokaryotic collagen-like proteins and uses thereof

Collagen-binding proteins from enterococcal bacteria

Collagen-binding proteins from enterococcal bacteria

Fibronectin binding protein compositions and methods of use

Decorin proteoglycan inhibitor of fibrinogen blood clotting